Product NDC: | 0703-4764 |
Proprietary Name: | Paclitaxel |
Non Proprietary Name: | Paclitaxel |
Active Ingredient(s): | 6 mg/mL & nbsp; Paclitaxel |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | INJECTION, SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0703-4764 |
Labeler Name: | Teva Parenteral Medicines, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA075184 |
Marketing Category: | ANDA |
Start Marketing Date: | 20091103 |
Package NDC: | 0703-4764-01 |
Package Description: | 1 VIAL, MULTI-DOSE in 1 CARTON (0703-4764-01) > 5 mL in 1 VIAL, MULTI-DOSE |
NDC Code | 0703-4764-01 |
Proprietary Name | Paclitaxel |
Package Description | 1 VIAL, MULTI-DOSE in 1 CARTON (0703-4764-01) > 5 mL in 1 VIAL, MULTI-DOSE |
Product NDC | 0703-4764 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Paclitaxel |
Dosage Form Name | INJECTION, SOLUTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 20091103 |
Marketing Category Name | ANDA |
Labeler Name | Teva Parenteral Medicines, Inc. |
Substance Name | PACLITAXEL |
Strength Number | 6 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Microtubule Inhibition [PE],Microtubule Inhibitor [EPC] |